Cargando…

A comparison of US and Australian men’s values and preferences for PSA screening

BACKGROUND: Patient preferences derived from an assessment of values can help inform the design of screening programs, but how best to do so, and whether such preferences differ cross-nationally, has not been well-examined. The objective of this study was to compare the values and preferences of Aus...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Kirsten, Brenner, Alison T, Lewis, Carmen, Sheridan, Stacey, Crutchfield, Trisha, Hawley, Sarah, Nielsen, Matthew E, Pignone, Michael P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852221/
https://www.ncbi.nlm.nih.gov/pubmed/24093428
http://dx.doi.org/10.1186/1472-6963-13-388
_version_ 1782478628166041600
author Howard, Kirsten
Brenner, Alison T
Lewis, Carmen
Sheridan, Stacey
Crutchfield, Trisha
Hawley, Sarah
Nielsen, Matthew E
Pignone, Michael P
author_facet Howard, Kirsten
Brenner, Alison T
Lewis, Carmen
Sheridan, Stacey
Crutchfield, Trisha
Hawley, Sarah
Nielsen, Matthew E
Pignone, Michael P
author_sort Howard, Kirsten
collection PubMed
description BACKGROUND: Patient preferences derived from an assessment of values can help inform the design of screening programs, but how best to do so, and whether such preferences differ cross-nationally, has not been well-examined. The objective of this study was to compare the values and preferences of Australian and US men for PSA (prostate specific antigen) screening. METHODS: We used an internet based survey of men aged 50–75 with no personal or family history of prostate cancer recruited from on-line panels of a survey research organization in the US and Australia. Participants viewed information on prostate cancer and prostate cancer screening with PSA testing then completed a values clarification task that included information on 4 key attributes: chance of 1) being diagnosed with prostate cancer, 2) dying from prostate cancer, 3) requiring a biopsy as a result of screening, and 4) developing impotence or incontinence as a result of screening. The outcome measures were self reported most important attribute, unlabelled screening test choice, and labelled screening intent, assessed on post-task questionnaires. RESULTS: We enrolled 911 participants (US:456; AU:455), mean age was 59.7; 88.0% were white; 36.4% had completed at least a Bachelors’ degree; 42.0% reported a PSA test in the past 12 months. Australian men were more likely to be white and to have had recent screening. For both US and Australian men, the most important attribute was the chance of dying from prostate cancer. Unlabelled post-task preference for the PSA screening-like option was greater for Australian (39.1%) compared to US (26.3%) participants (adjusted OR 1.68 (1.28-2.22)). Labelled intent for screening was high for both countries: US:73.7%, AUS:78.0% (p = 0.308). CONCLUSIONS: There was high intent for PSA screening in both US and Australian men; fewer men in each country chose the PSA-like option on the unlabelled question. Australian men were somewhat more likely to prefer PSA screening. Men in both countries did not view the increased risk of diagnosis as a negative aspect, suggesting more work needs to be done on communicating the concept of overdiagnosis to men facing a PSA screening decision. TRIAL REGISTRATION: This trial was registered at ClinicalTrials.gov (NCT01558583).
format Online
Article
Text
id pubmed-3852221
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38522212013-12-06 A comparison of US and Australian men’s values and preferences for PSA screening Howard, Kirsten Brenner, Alison T Lewis, Carmen Sheridan, Stacey Crutchfield, Trisha Hawley, Sarah Nielsen, Matthew E Pignone, Michael P BMC Health Serv Res Research Article BACKGROUND: Patient preferences derived from an assessment of values can help inform the design of screening programs, but how best to do so, and whether such preferences differ cross-nationally, has not been well-examined. The objective of this study was to compare the values and preferences of Australian and US men for PSA (prostate specific antigen) screening. METHODS: We used an internet based survey of men aged 50–75 with no personal or family history of prostate cancer recruited from on-line panels of a survey research organization in the US and Australia. Participants viewed information on prostate cancer and prostate cancer screening with PSA testing then completed a values clarification task that included information on 4 key attributes: chance of 1) being diagnosed with prostate cancer, 2) dying from prostate cancer, 3) requiring a biopsy as a result of screening, and 4) developing impotence or incontinence as a result of screening. The outcome measures were self reported most important attribute, unlabelled screening test choice, and labelled screening intent, assessed on post-task questionnaires. RESULTS: We enrolled 911 participants (US:456; AU:455), mean age was 59.7; 88.0% were white; 36.4% had completed at least a Bachelors’ degree; 42.0% reported a PSA test in the past 12 months. Australian men were more likely to be white and to have had recent screening. For both US and Australian men, the most important attribute was the chance of dying from prostate cancer. Unlabelled post-task preference for the PSA screening-like option was greater for Australian (39.1%) compared to US (26.3%) participants (adjusted OR 1.68 (1.28-2.22)). Labelled intent for screening was high for both countries: US:73.7%, AUS:78.0% (p = 0.308). CONCLUSIONS: There was high intent for PSA screening in both US and Australian men; fewer men in each country chose the PSA-like option on the unlabelled question. Australian men were somewhat more likely to prefer PSA screening. Men in both countries did not view the increased risk of diagnosis as a negative aspect, suggesting more work needs to be done on communicating the concept of overdiagnosis to men facing a PSA screening decision. TRIAL REGISTRATION: This trial was registered at ClinicalTrials.gov (NCT01558583). BioMed Central 2013-10-05 /pmc/articles/PMC3852221/ /pubmed/24093428 http://dx.doi.org/10.1186/1472-6963-13-388 Text en Copyright © 2013 Howard et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Howard, Kirsten
Brenner, Alison T
Lewis, Carmen
Sheridan, Stacey
Crutchfield, Trisha
Hawley, Sarah
Nielsen, Matthew E
Pignone, Michael P
A comparison of US and Australian men’s values and preferences for PSA screening
title A comparison of US and Australian men’s values and preferences for PSA screening
title_full A comparison of US and Australian men’s values and preferences for PSA screening
title_fullStr A comparison of US and Australian men’s values and preferences for PSA screening
title_full_unstemmed A comparison of US and Australian men’s values and preferences for PSA screening
title_short A comparison of US and Australian men’s values and preferences for PSA screening
title_sort comparison of us and australian men’s values and preferences for psa screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852221/
https://www.ncbi.nlm.nih.gov/pubmed/24093428
http://dx.doi.org/10.1186/1472-6963-13-388
work_keys_str_mv AT howardkirsten acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT brenneralisont acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT lewiscarmen acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT sheridanstacey acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT crutchfieldtrisha acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT hawleysarah acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT nielsenmatthewe acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT pignonemichaelp acomparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT howardkirsten comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT brenneralisont comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT lewiscarmen comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT sheridanstacey comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT crutchfieldtrisha comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT hawleysarah comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT nielsenmatthewe comparisonofusandaustralianmensvaluesandpreferencesforpsascreening
AT pignonemichaelp comparisonofusandaustralianmensvaluesandpreferencesforpsascreening